- by realhealthycbd
Discovered by Dr Raphael Mechoulam the Human Endocannabinoid System is the biochemical communication system of the human body. It is responsible for regulating the bodies physiology, our mood, and everyday experience.
Cannabinoids (CBD) are part of an exciting new development in the world of modern science. CBD’s are very misunderstood due to the fact that people still associate the Hemp plant with its sister the Marijuana plant. The difference between the two plants is simple.
The Hemp plant is high in CBD’s but has little to none of the THC
which is the compound that gives you the physcoactive effect of feeling
high. Marijuana is the opposite to its sister it has a high content of
THC and little to no CBD content.
The Endocannabinoid System has two receptors through out the body. There are CB1 and CB2 receptors, CB1 receptors are found in the brain and central nervous system, while CB2 receptors are found in most of the major organs. Cannabinoids are an endogenous compound which is found in our own bodies that bind to these receptors. this has helped advance our understanding of the human biology.
It has been scientifically proven that Cannabinoids and other components of cannabis can modulate many physiological systems in the human brain and body. Cannabinoids (CBD) are chemical compounds that trigger CB1 and CB2 receptors. There are more than 100 CBD’s that have been identified in the Hemp plant. The most studied of these compounds have been, Tetrahydrocannabinol (THC) and Cannabidiol (CBD). The human body is the only other source known to produce Cannabinoids, these are known as Anandamide and 2AG these occur naturally in the brain and body.
Over whelming scientific research that has been funded by the U.S. government has concluded that CBD is a potent anti-tumor, antioxidant, anti-spasm, anti-psychotic, anti-convulsive, and protects the central nervous system. CBD’s also activate serotonin which causes an anti-anxiety effect and a sense of well being.
Scientists associated with the International Cannabinoid Research Society (ICRS) have made it clear that there are a number of molecular pathways through which CBD’s provide a therapeutic impact. An example of this is a preclinical study performed by Dr. Sean McAllister. He and his colleagues at the California Pacific Medical Center in San Francisco have found that CBD’s destroy breast cancer cells. This is accomplished by reducing a gene called ID-1, which was discovered in several types of aggressive cancer. This strategy of using CBD’s to reduce the ID-1 gene has the potential to become a possible cancer treatment.
Cannabidiol has the potential to become a non-toxic therapy that could aggressively treat forms of cancer without any of the painful side effects of chemotherapy.
Reserach done by the company GW Pharmaceuticals has shown that CBD is very effect as an Analgesic when it is combined with whole plant THC. Several studies have shown the therapeutic advantage of combining CBD and THC. Especially when treating peripheral neuropathy, a painful condition that is associated with cancer, multiple sclerosis (MS), diabetes, and arthritis.